Vertex Acquires Artificial Intelligence Tax Capabilities from Ryan, LLC
June 12, 2024 07:05 ET
|
Vertex Inc.
KING OF PRUSSIA, Pa., June 12, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, announced today the acquisition of...
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
June 12, 2024 07:05 ET
|
Clearside Biomedical, Inc.
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - Robust Safety Profile and Encouraging Efficacy Data Reported Utilizing SCS Microinjector® - ...
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
June 12, 2024 07:00 ET
|
Taysha Gene Therapies, Inc.
Company to host webcast on Tuesday, June 18, 2024, at 8:00 AM Eastern Time Oral presentation by Elsa Rossignol, M.D., FRCP, FAAP, Principal Investigator of the REVEAL adolescent and adult trial at...
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients
June 12, 2024 07:00 ET
|
Athira Pharma, Inc.
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients
Singing Machine to Acquire SemiCab, a Leading AI Logistics Technology Company
June 12, 2024 07:00 ET
|
The Singing Machine Company, Inc.
SemiCab Generated $6 Million Revenue in 2023 Fort Lauderdale, FL, June 12, 2024 (GLOBE NEWSWIRE) -- The Singing Machine Company, Inc. (“Singing Machine”) (NASDAQ: MICS) – the worldwide leader...
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
June 12, 2024 07:00 ET
|
Dianthus Therapeutics, Inc.
Top-line results from Phase 2 MoMeNtum trial in Multifocal Motor Neuropathy anticipated in 2H 2026 Building a neuromuscular franchise with DNTH103 following the initiation of the Phase 2 MaGic trial...
Dorman Products announces the grand opening of an additional USA-based drive shaft manufacturing facility
June 12, 2024 07:00 ET
|
Dorman Products, Inc.
COLMAR, Pa., June 12, 2024 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (NASDAQ:DORM) is proud to announce the grand opening of a new drive shaft manufacturing facility in Virginia Beach, VA (USA). A...
Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis
June 12, 2024 07:00 ET
|
Tilray Brands, Inc.
This summer, Good Supply cannabis spotlights their most shareable and convenient formats, with exciting flavours that are perfect for the season ahead.
Affimed Reports First Quarter 2024 Financial Results & Business Update
June 12, 2024 06:30 ET
|
Affimed N.V.
- Initial data from the LuminICE-203 study shows 85.7% overall response rate (ORR) (6 of 7 patients); 4 out of 7 patients with complete response (CR) - - AFM28 shows single agent efficacy with 2...
Nathan's Famous, Inc. Reports Year End and Fourth Quarter Results
June 12, 2024 06:30 ET
|
Nathan's Famous Inc
JERICHO, N.Y., June 12, 2024 (GLOBE NEWSWIRE) -- Nathan's Famous, Inc. (NASDAQ:NATH) today reported results for its fiscal year and fourth quarter ended March 31, 2024. Effective June 12, 2024, the...